You are here

Ex vivo Conditioned Diabetic PBMNCs Promotes Wound Healing

Peripheral blood mononuclear cells (PBMNCs) isolated from patients can be employed in wound healing approaches in diabetic patients; however, the isolation of sufficient numbers of vasculogenic cells represents a significant problem. Towards solving this problem, researchers led by Rica Tanaka (Juntendo University, Tokyo, Japan) recently reported a practical serum‐free quantity‐control culture method that can restore function to PBMNCs isolated from diabetic patients. Indeed, these cells displayed high vasculogenic, anti‐inflammatory, and wound healing potential. For more details, see STEM CELLS Translational Medicine now!